Latest Content

Cara Curcio’s melanoma journey changed her life as a wife and mother, but treatment, family and hope have kept her moving forward.

Nicole Schultz was treated for acute myeloid leukemia as a teenager. Two decades later, chronic graft-versus-host disease and ongoing survivorship monitoring remain part of her care.

A gynecologic oncologist on the testing that shapes treatment, the side effect not to push through and why fertility questions can't wait.

Sixteen years after treatment, cancer fatigue is still my constant shadow. I can't cure it, so I've learned to manage it instead of letting it manage me.

Dr. Priscilla Merriam discusses why sarcoma is often mistaken for a benign growth, how treatment differs across more than 150 types and where patients can find expert care.

The FDA granted accelerated approval to Zenbexus with daratumumab and hyaluronidase-fihj and dexamethasone for previously treated multiple myeloma.

Sixteen years after my own cancer journey, I find myself reflecting on the lasting shadows of cancer and the connection survivors can offer one another.

Genomic testing can show whether a targeted treatment may be an option. In a Medicare study, fewer than 1 in 5 patients with cancer received it in 2023.

Black women with ovarian cancer had a 45% higher risk of death than White women, with the gap widest in high-vulnerability neighborhoods.

Nicole Schulz was 14 when she received an AML diagnosis. She shares what carried her through two transplants and 11 months in the hospital.

Adding sirexatamab did not delay cancer growth overall, but patients with higher levels of a blood protein called DKK1 went longer without their cancer worsening.

Laura Yeager reflects on attending a Bridgerton-themed gala as a flat-chested breast cancer survivor, finding humor and freedom in a room full of corsets and cleavage.

A multiple myeloma survivor and advocate answers the questions people ask most after a diagnosis, from maintenance therapy to stem cell transplant.